Het 84.7mg/25.3mg Injection
Marketer
Harson Laboratories
Salt Composition
Etofylline (84.7mg) + Theophylline (25.3mg)
Overview Het 84.7mg/25.3mg Injection
The injectable medication, containing 84.7mg/25.3mg of active components, is indicated for managing asthma and chronic obstructive pulmonary disease (COPD), a lung condition characterized by airflow obstruction. Its mechanism of action involves bronchial muscle relaxation, thereby facilitating easier breathing. Administration is strictly by a qualified healthcare professional (doctor or nurse), with dosage tailored to individual patient needs and response. Continuous use, as directed by your physician, is crucial; premature discontinuation may lead to symptom recurrence and disease exacerbation. Complete disclosure of all other medications to your healthcare provider is essential due to potential drug interactions. Commonly reported side effects include nausea, vomiting, gastrointestinal discomfort, headache, and agitation. These are usually transient and self-limiting. However, prompt medical attention is warranted for any concerning side effects. Prior to initiation of treatment, inform your physician of any pre-existing heart, kidney, or liver conditions to enable appropriate dose adjustment. Similarly, disclose any pregnancy, pregnancy planning, or breastfeeding.
Primary Ingredients of Het 84.7mg/25.3mg Injection
The provided text is "undefined," therefore, no rephrasing is possible.
Uses of Het 84.7mg/25.3mg Injection
Managing Chronic Obstructive Pulmonary Disease (COPD)
Major Benefits of Het 84.7mg/25.3mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Het 84.7mg/25.3mg Injection:
- Nausea
- Vomiting
- Headache
- Restlessness
How to use Het 84.7mg/25.3mg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
How Het 84.7mg/25.3mg Injection works:
The combined bronchodilator injection, containing 84.7mg Etofylline and 25.3mg Theophylline, facilitates respiration by easing airway muscle constriction and thereby increasing airflow.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Het 84.7mg/25.3mg Injection poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
The use of Het 84.7mg/25.3mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against the risks prior to prescribing. Consult your physician for guidance.
Breast feedingSAFE IF PRESCRIBED
The 84.7mg/25.3mg Het injection is considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant. Postponing breastfeeding for two to four hours following administration of the 84.7mg/25.3mg Het injection may further reduce infant exposure.
DrivingCONSULT YOUR DOCTOR
The effect of Het 84.7mg/25.3mg Injection on driving ability is undetermined. Refrain from operating a vehicle if experiencing symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Het 84.7mg/25.3mg Injection to individuals with renal impairment is scarce. Seek medical advice from your physician.
LiverCAUTION
Administering Het 84.7mg/25.3mg Injection to individuals with hepatic impairment requires careful consideration. Dosage modification of Het 84.7mg/25.3mg Injection might be necessary. Physician consultation is advised.
What if you forget to take Het 84.7mg/25.3mg Injection :
Should you inadvertently omit a scheduled dose of the Het 84.7mg/25.3mg Injection, seek immediate medical advice.
Facts to Know About Het 84.7mg/25.3mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Breathing |
3,018 People bought this recently